(Q36830290)

16 August 2017

1 reference

title

Beta-blockers to prevent symptomatic heart failure in patients with stage A and B heart failure (English)

1 reference

16 August 2017

0 references

David M Wild

1

1 reference

16 August 2017

Marrick Kukin

series ordinal

2

1 reference

16 August 2017

publication date

1 June 2007

1 reference

Current heart failure reports

16 August 2017

published in

1 reference

16 August 2017

volume

4

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

99-102

1 reference

Epidemiology and prevention of cardiac failure: Framingham Study insights

16 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11897-007-0007-4

Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11897-007-0007-4

Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial

21 January 2018

1 reference

12 December 2020

Economic impact of heart failure in the United States: time for a different approach

1 reference

12 December 2020

Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group

1 reference

12 December 2020

Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial

1 reference

12 December 2020

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

12 December 2020

Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management

1 reference

12 December 2020

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

12 December 2020

ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Gu

1 reference

12 December 2020

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

1 reference

12 December 2020

A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results

1 reference

12 December 2020

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

12 December 2020

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

1 reference

12 December 2020

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group

1 reference

12 December 2020

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study

1 reference

12 December 2020

Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators

1 reference

12 December 2020

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis

1 reference

12 December 2020

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

1 reference

12 December 2020

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

12 December 2020

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

1 reference

12 December 2020

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1 reference

12 December 2020

10.1007/S11897-007-0007-4

Identifiers

DOI

1 reference

16 August 2017

1 reference